Global Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

Global Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

Global Vaccines Market is anticipated to reach US$ 86.2 Billion by the year 2027. From a public health viewpoint, vaccines represent the most significant inventions. A vaccine refers to a natural element that enables the production of antibodies against several pathogens present in the body. It is commonly produced by utilizing disease-causing agents and chemical drugs that act as antigens in disease prevention. Besides, vaccines are primarily available in the recombinant, conjugate, inactivated, live attenuated, and toxoid vaccines.

The Global Vaccine Market Size is Projected to Expand at a CAGR of 8.62% During 2021-2027:

In recent years, the high prevalence of several infectious diseases primarily drives the need for vaccines. The increasing consumer awareness of adequate immunization for killing various infections catalyzes vaccine market development. In addition, governments' introduction of several vaccination programs across different endemic regions also propels the demand for vaccines. Further, the rising involvement of several global organizations, such as the UNICEF, World Bank, WHO, Bill & Melinda Gates Foundation, etc., in developing adequate vaccination facilities in the endemic regions is catalyzing the product demand.

COVID-19 Boost on the Global Vaccine Industry:

In 2020, the COVID-19 pandemic led to around half a million worldwide deaths, creating opportunities for a novel vaccine against COVID-19. Due to the pandemic, most pharmaceutical, healthcare, and biotechnology organizations have focused on wearable diagnostics kits, safety treatment vaccines, and medication against coronavirus. Most of the leading companies concentrate on finding a breakthrough vaccine against coronavirus.

Furthermore, the medical professionals had been committed to providing COVID-19 related services. As a result, pharmaceutical companies prioritized research and development of COVID-19 related health technologies, diagnostics, treatments, and vaccines. As per our analysis, the Global Vaccine Market was US$ 52.5 Billion in 2021.

Segmentation of Global Vaccines Market:

In terms of end-user, the vaccine market is divided into pediatrics and adults. The pediatric segment currently accounts for most of the vaccine market share, owing to the high demand for vaccines in infants, such as BCG, MMR, and DPT vaccines. Further, Adult vaccination is one of the most cost-effective strategies available in public health today. Every year, vaccine-preventable illnesses kill thousands of adults globally. Adult immunization includes the administration of approved vaccines provided to patients aged 18 years and older for medical indications.

In 2021 by Pfizer Vaccine Product Pipeline, XTANDI™ (enzalutamide) for adult men with metastatic hormone-sensitive prostate cancer (mHSPC, also known as metastatic castration-sensitive prostate cancer or mCSPC) (E.U.)

Based on disease indication, the vaccine market can be segmented into Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine. The bacterial diseases segment holds a significant position in the market due to higher meningitis, pneumococcal, and DTP sales. These are the first-line immunization for newborns and booster doses for pediatrics.

Likewise, the viral diseases segment is predicted to have the highest growth due to the forthcoming launch of viral vaccines and the increasing number of influenza and HPV products. Recently, Janssen Pharmaceutical Companies launched providing 200,000 Ebola regimens to the residents of Rwanda in East Africa, aiming to control the Ebola outbreak.

Key Players:

The pediatric vaccines industry consists of several major players, including GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur's, Pfizer, Inc., and CSL Limited. As per our analysis, the key players focus on business expansion to increase their revenue share by implementing mergers and acquisitions and new product development strategies.

Renub Research report titled “Global Vaccine Market, People Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine], By End User [Infants (Pediatric), & Adult], Companies (GlaxoSmithKline, Merck, Sanofi, Pfizer)” provides a complete analysis of Global Vaccine Industry.

Disease wise – The Market has been covered from 14 viewpoints

1. COVID-19 Vaccines
2. Influenza
3. Cervical Cancer
4. Zoster (Shingles)
5. MMR (Measles, Mumps, and Rubella)
6. Pneumonia
7. Meningitis
8. Hepatitis
9. Tap (Diphtheria, Tetanus, Pertussis)
10. Haemophilus influenzae type B
11. Polio
12. Rotavirus
13. Varicella
14. Combination Vaccine
15. Travel & Miscellaneous Vaccine

End Use - The Market has been covered from 2 viewpoints:

1. Infants (Pediatric)
2. Adults

Company Insights:

• Overview
• Recent Development
• Revenue Analysis

Company Analysis:

1. GlaxoSmithKline
2. Merck
3. Sanofi
4. Pfizer